Professor Timo Müller

Awards & Grants, Diabetes, IDO,

Timo Müller Receives 2026 Gill Transformative Investigator Award

Timo Müller, Director of the Institute for Diabetes and Obesity (IDO) at Helmholtz Munich and Professor at Ludwig-Maximilians-Universität München (LMU), has received the 2026 Gill Transformative Investigator Award. With this distinction, the Gill…

Professor Timo Müller

Diabetes, IDO,

Interview with Timo Müller About New Therapies for Obesity and Diabetes

Modern drugs for obesity and type 2 diabetes are based on a simple insight: metabolic pathways are not controlled by a single signal, but by many acting together. Prof. Timo D. Müller is Director of the Institute for Diabetes and Obesity (IDO) at…

Protein folding structure

New Research Findings, Diabetes, IDO,

FGF21 Helps Cells Cope with Protein Folding Stress

FGF21 is primarily known as a metabolic hormone. A new study by researchers at Helmholtz Munich and the Ludwig Maximilians University has now described a previously unknown mechanism through which FGF21 supports cells under protein folding stress:…

glucagon like peptide 1 glp1 7 36 molecule the glucagon like peptide 1 receptor has a strong effect on the management of type 2 diabetes mellitus

New Research Findings, Diabetes, IDO,

One Molecule, Two Effects: A New Drug Concept to Treat Obesity and Type 2 Diabetes

A team led by metabolism researcher Prof Timo D. Müller at Helmholtz Munich has developed a new approach for treating obesity and type 2 diabetes: a hybrid molecule uses the well-known GLP-1/GIP signalling pathway as a “door opener” and delivers an…

Professor Timo Müller

Awards & Grants, Diabetes, IDO,

Timo Müller Receives the ADA 2026 Outstanding Scientific Achievement Award

The American Diabetes Association (ADA) has announced the recipients of this year's National Scientific and Health Care Achievement Awards. Among this year’s awardees is Prof. Timo Müller, Director of the Institute for Diabetes and Obesity (IDO) at…

An experiment on the distribution of proteins in cells using molecular imaging technology.

AI, New Research Findings, Diabetes, IDO,

C-COMPASS: AI-Based Software Maps Proteins and Lipids Within Cells

A new tool developed by Helmholtz Munich and the German Center for Diabetes Research and the University of Bonn makes spatial proteomics and lipidomics easier to use – no coding required. C-COMPASS allows scientists to profile where proteins and…